Thursday 30 April 2020

Pathogen Reduction Systems Market to Undergo Significant Growth in Coming Years

Increasing prevalence of infectious diseases and surging demand for plasma protein to drive the growth of global pathogen reduction systems market
According to TechSci Research report, “Global Pathogen Reduction Systems Market By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction), By Application (Viruses, Fungi, Bacteria), By Product (Automated, Semi-Automated), By End User (Hospitals, ASCs, Blood Banks), By Region, Forecast & Opportunities, 2025”, the global pathogen reduction market is expected to witness significant rate of growth during the forecast period. There are several factors behind the growth of this market such as increasing research and development activities for development of new pathogen systems, which will lead to innovative and more effective treatments for the blood receiver. The rising prevalence of infectious diseases around the world is also accelerating the demand for pathogen reduction systems. Additionally, people are now more aware towards maintaining a healthy lifestyle and the government is also spending on providing best healthcare facilities. This is acting as a major factor for the growth of pathogen reduction systems globally. Moreover, the manufacturers are continuously undergoing clinical trials to increase their product portfolio. Along with this, increasing demand for plasma protein is also fueling the growth of pathogen reduction systems market. Furthermore, recent outbreak of COVID-19 is also anticipated to increase the demand for these systems around the world.
However, there are some factors restricting the growth of global pathogen reduction systems market. Lack of fair reimbursement is posing as a challenge before manufacturers. Also, for introduction of pathogen reduction treatments, many countries require not only the CE mark but licensing with the respective authorities, as treatment for pathogen reduction is regarded as creating a ‘new’ blood product.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "Global Pathogen Reduction Systems Market"
The global pathogen reduction systems market is segmented based on type, application, product, end user and region. Based on type, the market is segmented into platelet pathogen reduction and plasma pathogen reduction. The latter segment is the fastest growing segment in pathogen reduction systems market as emerging infections and bacterial contamination have led to an increasing demand for plasma pathogen reduction. Based on end user, the global pathogen reduction systems market is segmented into hospitals, ASCs and blood banks. The hospital segment accounts for largest market share as most of the tests to detect the presence of infections is carried out in hospitals. Also, pathogen reduction systems need trained professionals and therefore, most of the operation is conducted in hospitals.
Major players operating in the global pathogen reduction systems market include Terumo BCT, Inc., Macopharma SA, Cerus Corporation, AngioDynamics, Inc. and Octapharma AG. The market players are investing in R&D activities to increase their product portfolio. This will not only enhance their brand positioning but will also lead to development of advanced and novel methods for pathogen reduction. Governments and health organizations are also granting funds for development of more such medical devices, which is anticipated to provide a huge growth opportunity for pathogen reduction systems industry.
Customers can also request for 10% free customization on this report.
“North America currently dominates the global pathogen reduction systems market due to wide product availability and presence of advanced healthcare infrastructure in the region. However, the market is witnessing surging demand from Asia-Pacific region, prominently China. The country leads in the manufacture of pathogen reduction systems. Hence, marketers need to focus on budding markets like Asia-Pacific to increase their market reach,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Pathogen Reduction Systems Market By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction), By Application (Viruses, Fungi, Bacteria), By Product (Automated, Semi-Automated), By End User (Hospitals, ASCs, Blood Banks), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global pathogen reduction systems market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global pathogen reduction systems market.
Browse Related Reports
Europe Biosimilar Insulin Glargine & Lispro Market By End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe), Competition, Forecast & Opportunities, 2024
Asia Pacific Biosimilar Insulin Glargine & Lispro Market By End User (Type 1 Diabetes and Type 2 Diabetes), By Country (Japan, China, India, South Korea, Bangladesh, Pakistan), Competition, Forecast & Opportunities, 2024
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Posted by at No comments:
Labels: , , ,
Location: United States

North America to Dominate Laboratory Information System Market until 2025 – TechSci Research

Rising prevalence of chronic diseases and surging need for laboratory automation across the globe to drive the growth of global laboratory information system market
According to TechSci Research report, “Global Laboratory Information System Market By Product (Standalone LIS, Integrated LIS), By Component (Services, Software), By Delivery Mode (On-Premises, Cloud-Based), By End-user (Hospital Labs, Independent Labs, Physician Office Laboratories, Others), By Region, Forecast & Opportunities, 2025”, global laboratory information system market is expected to witness robust CAGR during the forecast period. Growing requirement for laboratory automation is one of the major factors accounting for the growth of global laboratory information system market. Moreover, development of integrated laboratory information systems is expected to bode well for the growth of global laboratory information system market through the forecast period. In addition to this, rising support for disease treatment methods and research by the governments across various economies is also anticipated to fuel the demand for associated technologies and solutions, thereby positively influencing the growth of global laboratory information system market. Also, laboratory information systems offers several benefits such delivering fast and accurate subtyping for diseases, decrease redundancy and costs, providing quick access to cancer data, and facilitating data collection and then integrating it through various types of instruments and systems, thereby fueling the growth of this market. However, there are certain factors that might hamper the growth of global laboratory information system market over the coming years such as high maintenance and service costs associated with laboratory information systems.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " Global Laboratory Information System Market "
Global laboratory information system market can be segmented based on product, component, delivery mode, end user, company, and region. Considering the component, the market is fragmented into services and software. The services segment dominated the global laboratory information system market in terms of largest market share until 2019 and is further anticipated to maintain its dominance during the forecast period as well, which can be accredited to their indispensable nature as well as repetitive requirement. Moreover, the end users depend on service providers for consulting, implementing services, data storage, maintenance, training, and regular upgrades of solutions, which is further anticipated to boost the segmental growth over the coming years. In terms of end user, the market is categorized into hospital labs, independent labs, physician office laboratories, others. Out of these, the hospital labs segment is forecast to grow at a high CAGR in the years to come, owing to increasing adoption of laboratory information systems in hospitals for reducing the waiting time for patients and improve the overall quality of diagnostics.
LabVantage, Abbott Laboratories, LabWare, McKesson Corporation, Thermo Fisher Scientific, LabLyn, Computing Solutions, Labworks LLC, Siemens, Dassault Systemes, Orchard Software Corporation, Sunquest Information Systems Inc., Cerner Corporation, Computer Programs and Systems, Inc., CompuGroup Medical AG, Meditech, Epic Systems Corporation, Schuyler House, LabHealth, American Soft Solutions Corp are among others are the leading players operating in global laboratory information system market. The players are adopting several growth strategies to enhance the market scenario of laboratory information system. Other competitive strategies include product launches; mergers & acquisitions; agreements, partnerships, and collaborations; and expansions to diversify their product portfolio to strengthen their market position.
customers can also request for 10% free customization on this report.
“North America is forecast to dominate the global laboratory information system market during the next five years on account of presence of several major players in the United States. Furthermore, increased reimbursements for pathology procedures is also contributing to the growing trend. Additionally, growing cases of cancer in the region are further anticipated to fuel the market over the coming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Laboratory Information System Market By Product (Standalone LIS, Integrated LIS), By Component (Services, Software), By Delivery Mode (On-Premises, Cloud-Based), By End-user (Hospital Labs, Independent Labs, Physician Office Laboratories, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global laboratory information system market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global laboratory information system market.
Browse Related Reports
Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Application (Infectious Diseases (Sepsis, Respiratory Diseases, Gastrointestinal Diseases, Nephrological Diseases, New Corona Virus (COVID-19), AIDS & Hepatitis), Antimicrobial Resistance & Health Associated Infections (Antimicrobial Resistance, HAIs, Others), Cardiovascular Emergencies, Personalized Medicine, Others(Industrial Applications (Agri-food sector, Biopharma, Cosmetics)), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, Academic & Medical Schools, Others), By Region, Forecast & Opportunities, 2025


Global Integrated Refinery Information System Market, By Type (P&ID, Electrical, Civil & Mechanical), By Application (Enterprise Asset Management, HSE Management, Instrument Management, Laboratory Information Management, Document Management), By Company and By Geography, Forecast & Opportunities, 2023
           
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Posted by at No comments:
Labels: , , ,
Location: United States

Wednesday 29 April 2020

Chemotherapy Market to Witness Robust Growth in the Coming Years – TechSci Research

Rising prevalence of cancer and increasing expenditure on oncology medicine & research to drive the growth of global chemotherapy market
According to TechSci Research report, “Global Chemotherapy Market By Drugs (Alone, Combination), By Type (Alkylating Agents, Nitrosoureas, Antimetabolites, Anti-tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Others), By Indication (Leukaemia, Lymphoma, Hodgkin Disease, Multiple Myeloma, Sarcoma, Bone Marrow Disease, Immune System Disorder), By Route of Administration (Intravenous, Orally, Transdermal, Intraperitoneal, Intrapleural, Intrathecal, Intravesical, Others), By End-User (Hospitals, Specialty Center, Others), By Region, Forecast & Opportunities, 2025”, the global chemotherapy market is expected to witness high growth rate during the forecast period owing to increasing prevalence of cancer around the world. Additionally, increasing funds and grant for research & development of oncology drugs and treatment is also boosting the growth of chemotherapy market. The reimbursements provided in various countries is also a major factor propelling the market growth. Apart from that, people are now aware of deadly cancer diseases and hence are willing to spend for the treatment of cancer. Thus, increasing expenditure on healthcare is also one of the major factors driving the growth of global chemotherapy market. Moreover, governments in various economies are also taking initiatives to provide best healthcare services to the people. This has led to establishment of various cancer research and treatment centers. The increase in healthcare centers and cancer treatment options is further expected to boost the growth of global chemotherapy market. After an early detection of cancer, most of the oncologists prefer chemotherapy treatment to avoid further multiplication of cancerous cells. This also prevents the further growth of tumors cells, thereby fueling demand for chemotherapy treatment around the world. However, the global chemotherapy market also faces some challenges. It is a time-consuming treatment and takes several months to show the symptoms of improvement. This might pose as a threat for the market growth. Also, the side-effects associated with chemotherapy is anticipated to restrain overall market growth.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "Global Chemotherapy Market"
The global chemotherapy market is segmented based on drugs, type, indication, route of administration, end-user and region. Based on type, the market is segmented into alkylating agents, nitrosoureas, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, corticosteroids and others. The alkylating agents holds dominance in the global chemotherapy market and is expected to undergo rapid growth during the forecast period as they stop the growth of tumor by crosslinking guanine nucleobases in DNA double-helix strands, directly attacking DNA. This is the most effective way of treating cancer. Based on route of administration, the global oncology drugs market is segmented into intravenous, orally, transdermal, intraperitoneal, intrapleural, intrathecal, intravesical and others. The intravenous segment accounted for largest market share in 2019. However, the oral segment is expected to grow at the highest CAGR during the forecast period as they come in different forms and can be taken even at home. Also, the continuous launch of new oral chemotherapy drugs is propelling the growth of this segment.
Major players operating in the global chemotherapy market include Abbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Fresenius Kabi AG, Novartis AG, Sanofi, Merck & Co., Pfizer Inc., Roche Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Tarveda Therapeutics, Bayer AG,Johnson & Johnson Services Inc. and Celltrion Inc., etc. The companies are investing on development of novel chemotherapy drugs, which is providing great opportunity for the market growth. Moreover, companies are doing partnership with other pharma companies to bring into novel products for chemotherapy treatment.
Customers can also request for 10% free customization on this report.
“Regionally, North America dominates the global chemotherapy market as it has world class cancer treatment facilities. The region is also witnessing rising number of cancer patients, which is fueling the market. However, Europe is expected to undergo highest CAGR during the forecast period on account of supportive government initiatives to develop novel drug products for treatment of cancer. Additionally, countries like Italy and France have some of the world’s best medical research centers and hospitals,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Chemotherapy Market Drugs (Alone, Combination), By Type (Alkylating Agents, Nitrosoureas, Antimetabolites, Anti-tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Others), By Indication (Leukaemia, Lymphoma, Hodgkin Disease, Multiple Myeloma, Sarcoma, Bone Marrow Disease, Immune System Disorder), By Route of Administration (Intravenous, Orally, Transdermal, Intraperitoneal, Intrapleural, Intrathecal, Intravesical, Others), By End-User (Hospitals, Specialty Center, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global chemotherapy market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global chemotherapy market.
Browse Related Reports
Global Liver Cancer Therapeutics Market By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Others), By Therapy (Targeted Therapy, Radiation Therapy, Immunotherapy, Chemotherapy, Others), By Equipment (Computed Radiography, Radiofrequency Equipment, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Chronic Infection with HBV Or HCV, Cirrhosis, Inherited Liver Disease, Diabetes, Others), By Route of Administration (Oral, Intra-Venous, Intra-Arterial, Intra-Tumoral, Intra-Portal, Intra-Splenic, Intra-Biliary), By Region, Forecast & Opportunities, 2025


Global Neoantigen Cancer Vaccine Market By Product (Personalized neo-antigen vaccine, Off-the shell neoantigen vaccine), By Neoantigen Type (Nucleic Acid, Dendritic Cell, Tumor Cell, Synthetic long peptide (SLP)), By Route of Administration (Intravenous, Intramuscular, Transdermal, Others), By Cell (Autologous, Allogenic), By Technology (Whole Genome Sequencing, Others), By Delivery Mechanism (Gene gun, Electroporation, Others), By Application (Melanoma, Brain Cancer, Others), By Region, Competition, Forecast & Opportunities, 2025

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Posted by at No comments:
Labels: , , , ,
Location: United States

Global Healthcare Robotics Market Size, Share & Forecast 2025 - TechSci Research

Posted by at No comments:
Labels: , , , ,
Location: United States

Real time PCR Market to Witness Significant Growth through 2025 – TechSci Research

Rising prevalence of target genetic disorders and increasing technological innovations in PCR tools to drive the growth of global real time PCR market
According to TechSci Research report, “Global Real time PCR Market[DK1]  By Product (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical (Pathogen Testing, Blood Screening, Oncology Testing), Research, Forensic, Others), By End-user (Hospitals & Diagnostic Labs, Research Laboratories & Academic Institutes, Pharma-Biotech, Clinical Research Organizations (CRO), Forensic Laboratories, Others), By Region, Forecast & Opportunities, 2025”, the global real time PCR market is expected to witness healthy growth rate during the forecast period. Growing prevalence of infectious diseases like HIV/AIDS and malaria coupled with increasing cases of genetic disorders are some of the factors propelling the growth of real time PCR market around the globe. Furthermore, technological advancements in PCR technology is also driving the growth of this market. Additionally, governments and various international organizations are also investing in PCR technologies and allocating funds and grants for research and development activities. This is also providing major boost to the global real time PCR market.Additionally, use of biomarker profiling for disease diagnostics has increased over the past few years. This has led to the rise in demand for real time PCR. Also, growing demand for Rapid Diagnostics Tests (RDT) is driving the growth of real time PCR market across the globe. Moreover, demand for RDT is increasing as it provides rapid results with the help of limited healthcare infrastructure. Hence, it is also contributing to the demand for real time PCRs, which are extensively used to conduct RDT diagnostic procedures across major healthcare establishments. However, high instrument cost of real time PCRs might hamper the growth of this market. Also, technical limitations of PCRs restrict their extensive use, thereby impacting the overall growth of real time PCR market.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "Global Real time PCR Market"  

The global real time PCR market is segmented based on product, application, end-user and region. Based on product, the market is segmented into instruments, reagents & consumables and software & services. The reagents and consumables segment holds largest market share in global real time PCR market owing to its technological benefits over traditional PCRs. Also, increasing number of probe-based multiplex genetic analysis procedures are leading to high demand for real time PCR reagents and consumables. Based on application, the global real time PCR market is segmented into clinical, research, forensic and others. The clinical segment is further divided into pathogen testing, blood screening and oncology testing. The clinical segment dominates the global real time PCR market and is expected to witness significant growth during the forecast years due to rising prevalence of diseases like cancer and genetic disorders. Additionally, clinical real time PCRs are extensively used for disease diagnosis and help in providing effective treatment.
Major players operating in the global real time PCR market include Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Abbott Laboratories., Takara Bio, Inc., Agilent Technologies, Inc., BioMerieux SA., Danaher Corporation, Merck KGaA., GE Healthcare, Fluidigm Corporation,Becton Dickinson and Company, Promega Corporation, Meridian Bioscience, Inc., Analytik Jena AG, Cepheid and others. The companies are adopting various growth strategies like research & development activities and merger & acquisitions to hold significant market share in global real time PCR market. For instance, in 2017, Bio-Rad, one of the leading companies in the field of real time PCRs, acquired RainDance Technologies to utilise RainDance’s droplet micro fluid technology for new product developments.
Customers can also request for 10% free customization on this report.
“Increased used of biomarkers for diagnosis of diseases like cancer, etc., is acting as a potential driver for real time PCR market. Moreover, with increased funds and grants by governments and various health organizations, the global real time PCR market is expected to witness an exponential growth until 2025. Research and development are key factors for the growth of any market and therefore, leading companies are indulging extensively in such activities to bring new and advanced technologies in the global market. Moreover, medical practitioners are also opting for real time PCRs instead of traditional PCRs due to the added advantage they offer over other PCR types,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Real time PCR Market By Product (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical (Pathogen Testing, Blood Screening, Oncology Testing), Research, Forensic, Others), By End-user (Hospitals & Diagnostic Labs, Research Laboratories & Academic Institutes, Pharma-Biotech, Clinical Research Organizations (CRO), Forensic Laboratories, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global real time PCR market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global real time PCR market.
Browse Related Reports
Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025
Global Portable Ventilator Market, By Type (Invasive Ventilation, Non-Invasive Ventilation), By Mode (Pressure Mode Ventilation; Volume Mode Ventilation; Combined Mode Ventilation), By Application (Aeromedical; Pediatrics; Domiciliary Ventilation; Non-Invasive Ventilation), By End User (Hospital; Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast & Opportunities, 2025
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656

Posted by at No comments:
Labels: , , , ,
Location: United States
Subscribe to: Posts (Atom)